CD274 and neoplasm: In a translational trial of metastatic renal cell carcinoma, bevacizumab treatment alone increased the trafficking of CD8+ T cells into the tumor, and the expression of immune related genes and cell markers, such as the major histocompatibility complex and PD-L1 [24].